BEST PRACTICE GUIDANCE-SUPPLEMENTARY PRESCRIBING
|
|
- Raymond Nelson
- 6 years ago
- Views:
Transcription
1 BEST PRACTICE GUIDANCE-SUPPLEMENTARY PRESCRIBING NON MEDICAL PRESCRIBING ADVISOR IMPLEMENTATION DATE: MAY 2009 REVIEW DATE: MAY 2010
2 Supplementary Prescribing The working definition of supplementary prescribing is: A voluntary partnership between a doctor or dentist and a supplementary prescriber to implement an agreed patient specific clinical management plan (CMP) with the patients agreement. What can be prescribed? There are no legal restrictions as to the clinical conditions that may be managed by a supplementary prescriber. The CMP may include any General Sales List (GSL), Pharmacy (P) or Prescription Only Medicine (POM) that is prescribable on the NHS. This includes: Controlled drugs-except those listed in schedule 1 of The Misuse of Drugs Regulations 2001 that are not intended for medicinal use. Products used outside their UK marketing authorisation (off label use) Drugs that do not have a UK medicinal market authorisation (unlicensed drugs). Best practice would dictate that a supplementary prescriber should agree not to prescribe any medicine outside his/her area of competence. Patient Consent The principle underlying the concept of supplementary prescribing-the prescribing partnership, must be explained in advance to the patient by either the independent or supplementary prescriber. The patient s consent (verbal or written) must be recorded in the CMP prior to entering into a prescribing agreement. Clinical Management Plans Essential Details An agreed clinical management plan (CMP) must be in place before supplementary prescribing can occur. This CMP must be patient specific and relate to the patient s condition which will be managed by the supplementary prescriber. More than one supplementary prescriber can be named on the CMP- a supplementary prescribing team-this may include nurses and prescribers from other professional groups. The CMP should be accessible from the patient record. Legally the CMP must include:
3 The name of the patient to whom the plan relates The illnesses or conditions which may be treated by the supplementary prescriber Reference to the medicines that may be prescribed by the supplementary prescriber- by named individual medicine or class of medicine. Any restrictions to the dose of the medicine (s) to be prescribed or the length of treatment Relevant guidelines utilised to inform prescribing practice. The circumstances within which the supplementary prescriber can vary the dosage, frequency and formulation of the specified medicines. The circumstances within which the supplementary prescriber should refer back to the independent prescriber. Known sensitivities of the patient to particular medicines Arrangement for notification of any adverse drug reactions The date on which prescribing arrangements commence and the date on which they should be reviewed The formal agreement to the CMP of the independent prescriber, the supplementary prescriber and the patient. Responsibilities Independent Prescriber-Doctor/Dentist The independent prescriber will be responsible for: the initial assessment of the patient, including diagnosing the patient and determining the medicines that may be prescribed by the supplementary prescriber under the CMP Reaching an agreement with the supplementary prescriber about the limits of their responsibility for prescribing and reviewwhich must be detailed in the CMP Carrying out a review of the patient s progress at appropriate intervals depending on the nature and stability of the patient s condition
4 Providing advice and support to the supplementary prescriber when required Appropriate sharing of the patient record with the supplementary prescriber Reporting adverse incidents within local and national risk management or clinical governance schemes Supplementary Prescriber The supplementary prescriber is responsible for: Working within their clinical competence and code of conduct and accepting professional accountability and clinical responsibility for their practice Prescribing for the patient in accordance with the CMP-this includes altering the medicines prescribed within the limits established in the CMP and monitoring and assessing the patient s progress as appropriate to their clinical condition and medicines prescribed Consulting the independent prescriber when necessary and passing prescribing responsibility back to the independent prescriber if they feel that the patient s condition can no longer be managed competently by them Documenting prescribing and monitoring activity in the patient record as soon as possible after the intervention and ideally within 24-48hrs. Reporting adverse incidents within local and national risk management or clinical governance schemes
5 References Department of Health, Social Services and Public Safety (DHSSPS) (2004) Best Practice Guidance for Supplementary Prescribing by Nurses within the HPSS in Northern Ireland DHSSPS Department of Health (DoH) (2007) Supplementary Prescribing-Clinical Management Plans DoH /TheNon-MedicalPrescribingProgramme/Supplementaryprescribing/DH_ Nicol J (2008) Summary of supplementary prescribing and the use of the Clinical Management Plan (CMP) East and South East England Specialist Pharmacy Services.
6 Appendix 1 CLINICAL MANAGEMENT PLANS 1. Nurse/AHP template-blank 2. Pharmacist template-blank 3. Nurse/AHP completed CMP 4. Pharmacist completed CMP
7 NURSE/AHP TEMPLATE CLINICAL MANGEMENT PLAN-BLANK Name of Patient: Patient medication sensitivities/allergies: Patient identification e.g. ID number, date of birth: Independent Prescriber(s): Supplementary Prescriber(s) Condition(s) to be treated Aim of treatment Medicines that may be prescribed by SP: Preparation Indication Dose schedule. Specific indications for referral back to the IP. Guidelines or protocols supporting Clinical Management Plan: Frequency of review and monitoring by: Supplementary prescriber Supplementary prescriber and independent prescriber Process for reporting ADRs: Shared record to be used by IP and SP: Agreed by independent prescriber(s) Date Agreed by supplementary prescriber(s) Date Date agreed with patient/carer
8 PHARMACIST TEMPLATE CLINICAL MANAGEMENT PLAN-BLANK linical Management Plan atient name: NHS number: DOB: DR/sensitivities: Process for reporting ADRs: edical problem Goals of therapy Treatment Plan Guidelines or protocols Details of medicines that may be prescribed by SP Monitoring Circumstances for referral back to IP supporting CMP greed by dependent escriber: equency of review by dependent prescriber: Date: Agreed by supplementary prescriber: Frequency of review by supplementary prescriber: Date: Agreed with patient date: Shared record to be used by IP and SP
9 NURSE/AHP COMPLETED CLINICAL MANAGEMENT PLAN Name of Patient: Patient medication sensitivities/allergies: John Brown Patient identification e.g. ID number, date of birth: 07/01/ Independent Prescriber(s): Dr. Smith & Partners Condition(s) to be treated Asthma Medicines that may be prescribed by SP: Supplementary Prescriber(s) Nurse 1, nurse 2 and nurse 3 Aim of treatment Control of asthma symptoms, prevention of exacerbations and achievement of best possible pulmonary function, with minimal side effects. Preparation Inhaled short acting beta 2 Agonists Inhaled steroids Long acting beta 2 agonist Leukotreine receptor antagonist Indication Relief of asthma symptoms at step 1 and above Prevention of asthma symptoms at step 2 and above Prevention of asthma symptoms at step 3 and above Dose schedule As detailed in: BNF 57 section 3 BTS/SIGN Asthma Guidelines 2008, chapter 4 (pharmacological management) and chapter 5 (inhaler devices), up to and including step 3. Specific indications for referral back to the IP Diagnosis in doubt Failure to achieve stated aims of treatment at step 3. Prednisolone Acute exacerbation As per BNF and guidelines above Failure to respond to prednisolone in an exacerbation Guidelines or protocols supporting Clinical Management Plan: Practice asthma guidelines Consult practice formulary for first choice of drug and device British Guideline on the Management of Asthma (2008) British Thoracic Society and Scottish Intercollegiate Guidelines Network Fife Formulary Frequency of review and monitoring by: Supplementary prescriber Supplementary prescriber and independent prescriber 3 yearly As indicated by response to Treatment, but no less than annually Process for reporting ADRs: SP to report to IP and record in records. Yellow card notification Shared record to be used by IP and SP: Computerised record Agreed by independent prescriber(s) Date Agreed by supplementary prescriber(s) Date Date agreed with patient/carer
10 PHARMACIST COMPLETED CLINICAL MANAGEMENT PLAN Clinical Management Plan XXXX Medical Practice Patient name: CHI Number: DOB: ADR/Sensitivities: Process for reporting ADRs: SP to record in patient notes, complete yellow card & inform IP Medical Problem Goals of therapy Treatment Plan Guidelines or protocols Details of medicines that may Monitoring Circumstances for referral supporting CMP by prescribed by SP. back to IP Essential 1. Reduce BP Thiazide diuretics +/- K 1. BP - 4/52 following 1. BP not at target and not 1. SIGN 2007 Hypertension < 140/85mmHg. sparing diuretic initiation of new therapytolerating other agents. 2. BHS IV Guidelines Promote continued Beta adrenoreceptor and 3-6/12 when stable.2. BP not at target and taking 3 3. NHS Fife ADTC Guidance on adherence to therapy. blocking drugs 2. U+Es - prior to use, agents management of hypertension 3. Reinforce lifestyle Dihydropyridine calcium at each dosage increase3. Unresolved compliance issues 4. Fife Formulary modification to help channel blockers and 4/52 after reaching reduce CVD risk. Alpha adrenoreceptor max tolerated dose. i.e. Smoking cessation blocking drugs diet, exercise, alcohol. Angiotensin converting enzyme inhibitors Angiotensin II receptor antagonists (ACE inhibitors, AIIRAs, diuretics.) Annually thereafter. 3. Blood glucose/ urinalysis annually. Dose schedule as per BNF 57 and British Hypertension Society Guidelines Frequency of review Frequency of review As dictated by monitoring Shared record to be Gpass + paper notes by Independent 12 months by Supplementary and patient progress. used by IP & SP: held in GP surgery. Prescriber: Prescriber: Agreed by Agreed by Date agreed Independent Supplementary with Patient: Prescriber: Date: Prescriber: Date:
Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP
Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland patient CMP nurse doctor For further information relating to Nurse Prescribing please contact the Nurse
More informationNon Medical Prescribing Policy Register No: Status: Public
Non Medical Prescribing Policy Policy Register No: 07049 Status: Public Developed in response to: Department of Health Policies, Prescribing Guidance & Legislation Contributes to CQC Outcome: 9 Consulted
More informationAll areas of the Trust All Trust staff All Patients Deputy Chief Nurse & Chief Pharmacist Final
Trust Policy and Procedure Document Ref. No: PP(15)233 Non-Medical Prescribing Policy For use in: For use by: For use for: Document owner: Status: All areas of the Trust All Trust staff All Patients Deputy
More informationAlabama Medicaid Pharmacy Override
Alabama Medicaid Pharmacy Override Therapeutic Duplication, Early Refill, Maximum Unit, Brand Limit Switchover, Dispense as Written, and Maximum Cost Override Criteria Instructions Alabama Medicaid provides
More informationSUPPLEMENTARY PRESCRIBING: PHARMACIST PRACTITIONERS
SUPPLEMENTARY PRESCRIBING: PHARMACIST PRACTITIONERS A Guide for Implementation within NHSScotland Scottish Executive Health Department SUPPLEMENTARY PRESCRIBING: PHARMACIST PRACTITIONERS A Guide for Implementation
More informationINDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY. Suffolk GP Federation Board
INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY Version: 1.0 Policy owner: Ratified by: Clinical Governance Lead Chief Executive Date approved: 28 th November 2014 Approved by: Suffolk GP Federation
More informationIssue: June 2009 PROFESSIONAL STANDARDS AND GUIDANCE FOR PHARMACIST PRESCRIBERS
Issue: June 2009 PROFESSIONAL STANDARDS AND GUIDANCE FOR PHARMACIST PRESCRIBERS PROFESSIONAL STANDARDS AND GUIDANCE FOR PHARMACIST PRESCRIBERS CONTENTS About this document 1 Background 1.1 Types of pharmacist
More informationNON-MEDICAL PRESCRIBING POLICY
NON-MEDICAL PRESCRIBING POLICY PROCEDURE NUMBER Clinical.186 PROCEDURE VERSION 2 (Review). RATIFYING COMMITTEE Policy and Professional Practice Forum DATE RATIFIED 20 October 2015 DATE OF EQUALITY & September
More informationPharmacy Medicine Use Review What s it all about?
Pharmacy Medicine Use Review What s it all about? 1. What is it? 1.1 Medicine use Review has been introduced under the Advanced Services tier of the New Pharmacy Contract in England & Wales. The aim of
More informationNon- medical Prescribing Policy
Non- medical Prescribing Policy February 2010 Policy Title: Non-medical Prescribing Policy Policy Reference Number: Acute10/005 Implementation Date: February 2010 Review Date: February 2012 Responsible
More informationCLINICAL PRACTICE EVALUATION II: CLINICAL SYSTEMS REVIEW
Diplomate: CLINICAL PRACTICE EVALUATION II: CLINICAL SYSTEMS REVIEW A. INFORMATION MANAGEMENT 1. Does your practice currently use an electronic medical record system? Yes No 2. If Yes, how long has the
More informationPHARMACIST HEALTH COACHING CARDIOVASCULAR PROGRAM. 1. Introduction. Eligibility Criteria
PHARMACIST HEALTH COACHING CARDIOVASCULAR PROGRAM 1. Introduction Heart disease and stroke are among the leading causes of hospitalization and death in Canada. In 2008, nearly 30% of all deaths reported
More informationCommunity Pharmacy- Non-Medical Prescribing
Community Pharmacy- Non-Medical Prescribing Harry McQuillan Chief Executive Officer Community Pharmacy Scotland 1 Non-Medical Prescribing Use of non-medical prescribing is an underpinning key component
More informationShared Care Agreements for Medicines
Shared Care Agreements for Medicines Author: Scott Garden, Chief Pharmacist, Acute Services Version: 1.0 Authorised by: NHS Fife Area Drug and Therapeutics Committee Date of Authorisation: Review Date:
More informationNON-MEDICAL PRESCRIBING POLICY
NON-MEDICAL PRESCRIBING POLICY To be read in conjunction with the Medicines Policy, Controlled Drug Policy and the FP10 Prescribing Forms Policy Version: 5 Date of issue: August 2017 Review date: August
More informationNon Medical Prescribing Policy
Non Medical Prescribing Policy Author: Sponsor/Executive: Responsible committee: Ratified by: Consultation & Approval: (Committee/Groups which signed off the policy, including date) This document replaces:
More informationWhat is prescribing? Proposal. Non-Medical Prescribing. 4 Domains of Prescribing. Mapping the 4 Domains of Prescribing.
Non-Medical Charles Mitchell What is prescribing? Director CSEP, University of Queensland Senior Medical Advisor, MSQ, QH Proposal should be considered in a similar way to procedures Where a combination
More information2017 Congestive Heart Failure. Program Evaluation. Our mission is to improve the health and quality of life of our members
2017 Congestive Heart Failure Program Evaluation Our mission is to improve the health and quality of life of our members 2017 Congestive Heart Failure Program Evaluation Program Title: Congestive Heart
More informationUncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES
Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE SECTION 9(a) UNLICENSED MEDICINES BACKGROUND and PURPOSE Under the Medicines Act 1968 (EEC Directive 65/65), a company
More informationNHS Fife. Patient Group Direction for Named Community Pharmacists to Supply
Patient Group Direction for Named Community Pharmacists to Supply Senna tablets 7.5mg or Senna syrup 7.5mg/5ml (Total sennosides calculated as sennoside B) For patients aged 16 years and older prescribed
More informationExpiry Date: January 2009 Template Version: Page 1 of 7
YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Exclusion criteria: Cautions/Need for
More informationNHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION)
SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION) CONTENTS POLICY SUMMARY... 2 1. SCOPE... 4 2. AIM... 4 3. BACKGROUND... 4 4. POLICY STATEMENTS... 5 4.1. GENERAL STATEMENTS... 5 4.2 UNLICENSED
More informationGG&C PGD ref no: 2011/841 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2011/841 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Exclusion criteria:
More informationNurse Prescribing in Heart Failure (Integrated Service)
Nurse Prescribing in Heart Failure (Integrated Service) Liz Killeen Community Heart Failure CNS & RNP. Galway PCCC. Introduction. Heart Failure affects more than 120,000 Irish people and is one of the
More informationNon-Medical Prescribing Policy December 2016
1 Policy Title Policy Reference Number Acute17/002 Implementation Date Review Date 30 September 2018 or earlier subject to changes in legislation or review Responsible Officer Head of Pharmacy & Medicines
More informationExpiry Date: January 2009 Template Version: Page 1 of 7
YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Patients who require an antihistamine
More informationNHS Lanarkshire Policy for the Availability of Unlicensed Medicines
NHS Lanarkshire Policy for the Availability of Unlicensed Medicines Prepared by: NHS Lanarkshire Chief Pharmacist Endorsed by: Area Drug & Therapeutic Committee Previous Version/Date: Primary Policy Date:
More informationNon-Medical Prescriber Registration Policy
Non-Medical Prescriber Registration Policy REFERENCE NUMBER Non medical prescribing policy VERSION V1 APPROVING COMMITTEE & DATE Clinical Executive Committee 4.8.15 REVIEW DUE DATE August 2018 1 1. Introduction
More informationREPEAT PRESCRIBING POLICY
REPEAT PRESCRIBING POLICY THERE ARE FOUR STAGES: 1. Initiation/ Request 2. Production/ Authorisation 3. Clinical control/ Review 4. Management control The GP should retain an active involvement throughout
More informationEMERGENCY CARE DISCHARGE SUMMARY
EMERGENCY CARE DISCHARGE SUMMARY IMPLEMENTATION GUIDANCE JUNE 2017 Guidance for implementation This section sets out issues identified during the project which relate to implementation of the headings.
More informationPATIENT GROUP DIRECTION
PATIENT GROUP DIRECTION FOR THE SUPPLY OF FUSIDIC ACID CREAM 2% FOR THE TREATMENT OF IMPETIGO BY COMMUNITY PHARMACISTS UNDER THE PHARMACY FIRST SERVICE IN NHS HIGHLAND THE COMMUNITY PHARMACIST SEEKING
More informationNon-Medical Prescribing Passport. Reflective Log And Information
Non-Medical Prescribing Passport Reflective Log And Information Non-Medical Prescribing Continued Profession Development Log NMPs must refer to their regulatory bodies requirements for maintaining and
More informationLong-Term Care Medication Management: A Demonstration Project. Training Support Deck July 2016
Long-Term Care Medication Management: A Demonstration Project Training Support Deck July 2016 Overview Background Purpose and Guiding Principles of Demonstration Project Targeted Drug Classes Sample Scenario
More informationUnlicensed Medicines Policy Document
Unlicensed Medicines Policy Document Effective: February 2002 (Intranet 2006) Review date: February 2007 A. Introduction In order to ensure that medicines are safe and effective the manufacture and sale
More informationMEDS TO BEDS AND CARE MANAGEMENT MEDICATION ASSESSMENT TOOLKIT: FOR HOSPITAL TEAM AND PHARMACISTS
MEDS TO BEDS AND CARE MANAGEMENT MEDICATION ASSESSMENT TOOLKIT: FOR HOSPITAL TEAM AND PHARMACISTS Implementation Toolkit Last Updated: 02/2018 OneCity Health Services 199 Water Street, 31st Floor, New
More informationGROUP PROTOCOL FOR THE MANAGEMENT OF SIMPLE INDIGESTION. Version 5 December 2017
GROUP PROTOCOL FOR THE MANAGEMENT OF SIMPLE INDIGESTION Version 5 December 2017 RATIFYING COMMITTEE Drugs and Therapeutics Group DATE RATIFIED MAUP EXPIRES December 2020 EXECUTIVE SPONSOR Chief Nurse MAUP
More informationData Acquisition & Transmission
Using Clinically-Enhanced Claims Data to Guide Treatment of Acute Heart Failure An AHRQ Grant to MHA Data Acquisition & Transmission Pharmacy Data Overview of Data Acquisition Strategy Establish data specifications
More informationSouth East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide
South East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide 1. Introduction 1.1 This policy has been developed by the South East London Clinical Commissioning
More informationNon medical prescribing policy. Document author Assured by Review cycle. 1. Introduction Purpose or aim Scope...3
Non medical prescribing policy Board library reference Document author Assured by Review cycle P015 Non medical prescribing lead Quality and Standards Committee 3 years This document is version controlled.
More informationPHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK
PHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK 0 CONTENTS Course Description Period of Learning in Practice Summary of Competencies Guide to Assessing Competencies Page 2 3 10 14 Course
More informationDocument Details. notification of entry onto webpage
Document Details Title Patient Group Direction (PGD) Administration of sodium chloride 0.9% injection by registered professionals Trust Ref No 1987-38096 Local Ref (optional) Main points the document As
More informationNHS PCA (P) (2015) 17 ANNEX B. Specials Frequently Asked Questions for Community Pharmacy. Pre-authorisation:
ANNEX B Specials Frequently Asked Questions for Community Pharmacy Pre-authorisation: Q: When do I need to seek authorisation? A: You need to seek authorisation for all Specials manufactured medicines
More informationMedicines Reconciliation: Standard Operating Procedure
Clinical Medicines Reconciliation: Standard Operating Procedure Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation
More informationEvaluation of the Hywel Dda Community Pharmacist pilot optimising medicines treatment in heart failure.
Evaluation of the Hywel Dda Community Pharmacist pilot optimising medicines treatment in heart failure. Authors: Gareth Holyfield (Principal Pharmacist, Public Health Wales) Don Wilkes (Community Pharmacist,
More informationMedicines Management Strategy
Medicines Management Strategy 2012 2014 Directorate responsible for the strategy: Medical and Governance Directorate Staff group to whom it applies: All clinical staff and Trust managers Issue date: 30/6/12
More informationTemplate (to be adapted by care home) Medication to be administered on a PRN (when required) basis in a care home environment
Template (to be adapted by care home) Medication to be administered on a PRN (when required) basis in a care home environment The PRN Purpose & Outcome Protocol (PRN POP) Background The term PRN (from
More informationPatient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders.
Patient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders. This document authorises the supply of Fusidic Acid Cream 2% by registered
More informationPatient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019
THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS: CLINICAL COMMISSIONING GROUP: Doncaster CCG, Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire
More informationRole of Clinical Pharmacist in Primary Care Clinic HYOJIN SUNG, PHARM.D SALEM HEALTH MEDICAL GROUP OSMA ANNUAL CONFERENCE APRIL 14, 2018
Role of Clinical Pharmacist in Primary Care Clinic HYOJIN SUNG, PHARM.D SALEM HEALTH MEDICAL GROUP OSMA ANNUAL CONFERENCE APRIL 14, 2018 Objectives Understand the scope of practice for pharmacist and role
More informationPRESCRIBING SUPPORT TECHNICIAN:
PRESCRIBING SUPPORT TEAM AUDIT: CARDURA XL (Updated Sept 09) DATE OF AUTHORISATION: AUTHORISING GP: PRESCRIBING SUPPORT TECHNICIAN: SUMMARY Cardura XL is a once daily, extended release preparation of doxazosin
More informationPrescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services
Prescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services Document Purpose Version 2.2 To detail the specific contractual issues associated with prescribing
More informationStandard Operating Procedure for the administration of Red and Amber Drugs within Integrated Community Care Services
Standard Operating Procedure for the administration of Red and Amber Drugs within Integrated Community Care Services Reference No: Version: 1 Author: Emma Baggaley First Issued On: 1 st March 2018 Latest
More informationNon Medical Prescribing Guidelines
TRUST-WIDE CLINICAL GUIDELINES DOCUMENT Non Medical Prescribing Guidelines Policy Number: Scope of this Document: Recommending Committee: Approving Committee: MM05 All Staff Drugs and Therapeutics Committee
More informationScotia College of Pharmacists Standards of Practice. Practice Directive Prescribing of Drugs by Pharmacists
Scotia College of Pharmacists Standards of Practice Practice Directive Prescribing of Drugs by Pharmacists September 2014 ACKNOWLEDGEMENTS This Practice Directives document has been developed by the Prince
More informationPrinciples of Shared Care Protocols
Principles of Shared Care Protocols 1 Robust shared care arrangements facilitate the safe transition of medicines for use in a specified condition between secondary and primary care clinicians with the
More informationNurse prescribing in substance misuse February 2005, updated May 2005
Nurse prescribing in substance misuse February 2005, updated May 2005 1. Introduction This briefing aims to clarify the current situation in relation to nurse prescribing in the substance misuse sector.
More informationCOMMUNITY PHARMACY MINOR AILMENTS SERVICE
COMMUNITY PHARMACY MINOR AILMENTS SERVICE SUPPORTING SELF-CARE OCTOBER 2010 CONTENTS Index Page No 1 Introduction 3 2 Service Specification 4 3 Consultation Procedure 7 4 Re-ordering Documentation 10 Appendices
More informationUnlicensed Medicines Policy
Unlicensed Medicines Policy This procedural document supersedes: PAT/MM 4 v.3 Policy and Procedure for the Use of Unlicensed Medicines Did you print this document yourself? The Trust discourages the retention
More information2015 Congestive Heart Failure. Program Evaluation. Our mission is to improve the health and quality of life of our members
2015 Congestive Heart Failure Program Evaluation Our mission is to improve the health and quality of life of our members 2015 Congestive Heart Failure Program Evaluation Program Title: Congestive Heart
More informationADMINISTRATION OF MEDICINE
ADMINISTRATION OF MEDICINE Contents Pages Policy Statement 1 Administering of Medicines during School Hours 1 2 Health Care Plans 2-3 Record Keeping 3 Educational Visits and Activities off-site 3 Refusing
More informationSupporting Children at School with Medical Conditions
Introduction Children and young people with medical conditions are entitled to a full education and have the same rights of admission to school as other children. This means that no child with a medical
More informationThis controlled document shall not be copied in part or whole without the express permission of the author or the author s representative.
This document is also available in large print and other formats and languages, upon request. Please call NHS Grampian Corporate Communications on (01224) 551116 or (01224) 552245. This controlled document
More informationNON MEDICAL PRESCRIBING POLICY
NON MEDICAL PRESCRIBING POLICY Document Summary This Policy provides the framework and standards for Non-Medical Prescribing. The application of this policy will ensure that all non-medical prescribers
More informationCompetencies for NHS Health Check Enhanced Service using the General Level Framework & Service Specification
Competencies for NHS Health Check Enhanced Service using the General Level Framework & Service Specification This is a comprehensive mapping of the GLF against the enhanced service specification (where
More informationAll Wales Multidisciplinary Medicines Reconciliation Policy
All Wales Multidisciplinary Medicines Reconciliation Policy June 2017 This document has been prepared by the Quality and Patient Safety Delivery Group of the All Wales Chief Pharmacists Group, with support
More informationCaribbean Health Financing Conference. Curacao, 31 October 2012
Caribbean Health Financing Conference Curacao, 31 October 212 Objective: Embark on the train towards value based health care Our business is to create value, not (only) to control costs Episode registration
More informationRULES FOR STUDENT POSSESSION AND ADMINISTRATION OF ASTHMA, ALLERGY AND ANAPHYLAXIS MANAGEMENT MEDICATIONS OR OTHER PRESCRIPTION MEDICATIONS
DEPARTMENT OF EDUCATION Colorado State Board of Education RULES FOR STUDENT POSSESSION AND ADMINISTRATION OF ASTHMA, ALLERGY AND ANAPHYLAXIS MANAGEMENT MEDICATIONS OR OTHER PRESCRIPTION MEDICATIONS 1 CCR
More informationabcdefghijklmnopqrstu
NHS Circular: PCA (P)(2011) 6 Health and Healthcare Improvement Directorate Pharmacy and Medicines Division abcdefghijklmnopqrstu Dear Colleague ADDITIONAL PHARMACEUTICAL SERVICES MINOR AILMENT SERVICE
More informationPatient Group Direction For the supply of Fusidic Acid 2% Cream
Patient Group Direction For the supply of Fusidic Acid 2% Cream This Patient Group Direction (PGD) is a specific written instruction for the supply of Fusidic Acid 2% Cream to groups of patients who may
More informationSection Title. Prescribing competency framework Catherine Picton, Lead author
Prescribing competency framework Catherine Picton, Lead author What is in this presentation Context Uses of the competency framework Scope of the updated prescribing competency framework Introduction to
More informationDisease State Management Clinics: A Pharmacist Perspective
Disease State Management Clinics: A Pharmacist Perspective Eva Berrios Colon, Pharm.D, MPH, BCPS Associate Professor, Touro College of Pharmacy Email: evb9001@nyp.org 5/12/11 The Brooklyn Hospital Center
More informationThe Pulmonary Hypertension Service Specification (Adult)
Understanding the management of Pulmonary Hypertension in adults in the UK Short guide 2: The Pulmonary Hypertension Service Specification (Adult) This project was jointly developed by PHA UK and Actelion
More informationPGDs are permitted for use only by registered health professionals (see enclosed link for full list
NHS England North - Yorkshire and the Humber Region Protocol for the Development, Authorisation and Use of Patient Group Directions for the National Immunisation Programmes 1. Introduction The preferred
More informationSTUDENTS 3416 page 1 of 4 Administering Medicines to Students
0 1 0 1 Livingston School District STUDENTS page 1 of Administering Medicines to Students Medication means prescribed drugs and medical devices that are controlled by the U.S. Food and Drug Administration
More informationNew Medicine Service (NMS) data definitions
New Medicine Service (NMS) data definitions December 2013 The data reported to NHS England Area Teams (ATs) is designed to provide useful information to commissioners. The reporting periods for the New
More informationBe the best you can be, every day. Medicines Policy
Be the best you can be, every day Medicines Policy December 2016 Introduction THIS DOCUMENT IS a statement of the aims, principles and strategies for administering medicines at North Downs Primary School.
More informationAppendix 2 to NMP policy Prescribing Governance Framework Standards for Supplementary and Independent Non-Medical Prescribers at SCH
Appendix 2 to NMP policy Prescribing Governance Framework Standards for Supplementary and Independent Non-Medical Prescribers at SCH All prescribers and their managers/professional leads should ensure
More informationNHS community pharmacy advanced services Briefing for GP practices
NHS community pharmacy advanced services Briefing for GP practices August 2013 This document has been developed jointly by NHS Employers, the Pharmaceutical Services Negotiating Committee (PSNC) and the
More informationProfessional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess.
Professional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess. Number Outcome SBA SBA-1 SBA-1.1 SBA-1.2 SBA-1.3 SBA-1.4 SBA-1.5 SBA-1.6 SBA-1.7
More informationNewfoundland and Labrador Pharmacy Board
Newfoundland and Labrador Pharmacy Board Standards of Practice Prescribing by Pharmacists August 2015 Table of Contents 1) Introduction... 1 2) Requirements... 1 3) Limitations... 1 4) Operational Standards...
More informationManaging medicines in care homes
Managing medicines in care homes http://www.nice.org.uk/guidance/sc/sc1.jsp Published: 14 March 2014 Contents What is this guideline about and who is it for?... 5 Purpose of this guideline... 5 Audience
More informationNHS Lothian Patient Group Direction Version: 001
PATIENT GROUP DIRECTION FOR THE SUPPLY OF FUSIDIC ACID CREAM 2% TO TREAT MINOR STAPHYLOCOCCAL SKIN INFECTIONS (IMPETIGO) IN PATIENTS AGED OVER 2 YEARS BY PHARMACISTS WORKING WITHIN NHS LOTHIAN COMMUNITY
More informationSection 6: Referral record headings
Section 6: Referral record headings Referral record standards: the referral headings are primarily intended for recording the clinical information in referral communication between general practitioners
More informationAsthma Disease Management Program
Asthma Disease Management Program A: Program Content GHC-SCW is committed to helping members, and their practitioners, manage chronic illness by providing tools and resources to empower members to self-manage
More informationMANAGING MEDICINES POLICY
Introduction From time to time, children may need to take prescribed drugs during the school day, to treat a condition which is not severe enough to keep them off school or for the treatment of a long
More informationOPAT CELLULITIS PATHWAY
OPAT CELLULITIS PATHWAY ANY exclusion criteria for OPAT Sepsis syndrome Active drug/alcohol abuse Active underlying orthopaedic condition Craniofacial cellulitis Failure to improve with > 48hrs IV Rx YES
More informationGROUP PROTOCOL FOR THE MANAGEMENT OF SIMPLE MOUTH ULCERS. Version 4 December 2017
GROUP PROTOCOL FOR THE MANAGEMENT OF SIMPLE MOUTH ULCERS Version 4 December 2017 RATIFYING COMMITTEE Drugs and Therapeutics Group DATE RATIFIED MAUP EXPIRES December 2020 EXECUTIVE SPONSOR Chief Nurse
More informationSupply of Fusidic Acid Cream 2% by Community Pharmacists for the treatment of impetigo in patients 2 years of age and over.
Supply of Fusidic Acid Cream 2% by Community Pharmacists for the treatment of impetigo in patients 2 years of age and over. November 2017 Review Nov 2019 Signatures of those developing the Patient Group
More informationGG&C PGD ref no: 2018/1562 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2018/1562 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: For active immunisation in adults
More informationProcess and methods Published: 23 January 2017 nice.org.uk/process/pmg31
Evidence summaries: process guide Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationSafer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS
Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS Steve Chaplin describes the NPSA s anticoagulant patient safety alert and the measures it recommends for making the
More informationCHAPTER 9 PERFORMANCE IMPROVEMENT HOSPITAL
CHAPTER 9 PERFORMANCE IMPROVEMENT HOSPITAL PERFORMANCE IMPROVEMENT Introduction to terminology and requirements Performance Improvement Required (Board of Pharmacy CQI program, The Joint Commission, CMS
More informationEuropean Commission consultation on measures for improving the recognition of medical prescriptions issued in another member state
European Commission consultation on measures for improving the recognition of medical prescriptions issued in another member state NHS European Office response The National Health Service (NHS) is one
More informationNova Scotia College of Pharmacists. Standards of Practice. Prescribing Drugs
Nova Scotia College of Pharmacists Standards of Practice November 2015 Acknowledgements Acknowledgements This Standards of Practice document has been developed by the Nova Scotia College of Pharmacists
More informationConsultation Group: See relevant page in the PGD. Review Date: October 2016
Patient Group Direction For The Administration Of Adrenaline (Epinephrine) By Trained Nurses In The Management Of Cardiac Arrest In The Medical High Dependency Unit/Coronary Care Unit (MHDU/CCU) Working
More informationDocument Details. Patient Group Direction
Document Details Title Patient Group Direction (PGD) CO-CODAMOL 30/500 TABLETS FOR MINOR INJURIES UNITS Trust Ref No 1956-35206 Local Ref (optional) Main points the document treatment of moderate pain
More informationAdministration of blood components. Denise Watson Patient Blood Management Practitioner 11th January, 2016
Administration of blood components Denise Watson Patient Blood Management Practitioner 11th January, 2016 Introduction British Committee for Standards in Haematology guidelines Administration process Case
More informationNHS Grampian Pharmaceutical Care Of Patients Receiving Treatment For Hepatitis C Service Specification
NHS Grampian Pharmaceutical Care Of Patients Receiving Treatment For Hepatitis C Service Specification 1. Service Objectives 1.1 The specific objectives of the service to provide pharmaceutical care to
More informationMedicines Management Policy
Medicines Management Policy Name of Policy: Purpose of Policy: Directorate responsible for Policy Name & Title of Author: Medicines Management Policy The Southern HSC Trust recognises that almost all patients
More informationRULE RESPONSIBILITIES OF A PHYSICIAN WHO ENGAGES IN DRUG THERAPY MANAGEMENT WITH A COLORADO LICENSED PHARMACIST
DEPARTMENT OF REGULATORY AGENCIES Colorado Medical Board RULE 900 - RESPONSIBILITIES OF A PHYSICIAN WHO ENGAGES IN DRUG THERAPY MANAGEMENT WITH A COLORADO LICENSED PHARMACIST 3 CCR 713-32 [Editor s Notes
More information